ArticlePloS one2025
Shifting respiratory pathogens: Post-COVID-19 trends in community-acquired infections in underserved communities.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.PLoS computational biology · 2026Article
- Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.medRxiv : the preprint server for health sciences · 2026Article
- Monitoring of RSV-A and RSV-B Circulation in Poland Across Three Post-Pandemic Seasons (2022-2025).Viruses · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Respiratory tract infections, caused by various bacteria and viruses, pose a significant global health burden. In Lebanon, post-COVID-19 epidemiological data on respiratory infections remain scarce. To address this gap, this multicenter study investigates the epidemiology of community-acquired acute respiratory infections among children and adults in Tripoli, North Lebanon. From May 2023 to February 2024, nasopharyngeal samples were collected from outpatients with acute respiratory infections visiting hospitals and pediatric clinics in Tripoli. Samples were analyzed using BioFire® Respiratory Panel 2.1 Plus (bioMérieux, France), which targets 23 pathogens, including 19 viruses and four bacteria. We used multivariable logistic regression models to identify the determinants of respiratory infections and examine associations between respiratory pathogens. Among 324 enrolled patients, 69.1% were co-infected with at least one pathogen. Human rhinovirus/enterovirus was the most prevalent (27.2%), followed by influenza A (19.8%), particularly influenza A/H1-2009 (16.4%), and RSV (11.4%). SARS-CoV-2 was still circulating with a prevalence of 6.8%. Classical human coronaviruses accounted for 6.1% of infections, with HCoV-NL63 (2.8%) being the most common. Parainfluenza viruses were identified in 5.2% of patients, with type 4 (2.5%) being the most prevalent, followed by type 3 (1.5%), type 1 (1.2%), and type 2 (0.3%). Logistic regression analysis revealed that human rhinovirus/enterovirus infection decreased the likelihood of influenza A (OR=0.25; 95%CI = 0.10-0.54; P = 0.001) or SARS-CoV-2 (OR=0.21; 95%CI = 0.03-0.75; P = 0.039) co-infection. Additionally, our logistic regression models identified significant associations between various determinants, symptoms, and common viruses, including a lower likelihood of influenza A (OR=0.23; 95%CI = 0.06-0.76; P = 0.019) and RSV (OR=0.29; 95%CI = 0.10-0.76; P = 0.017) infection among patients with higher educational levels. Notably, parainfluenza virus infections occurred significantly more in refugee patients (OR=7.22; 95%CI = 1.19-37.0; P = 0.020) compared to the host community. In conclusion, this study provides critical insights into the post-pandemic epidemiology of respiratory infections in Lebanon, informing clinicians, health authorities, and policymakers to optimize diagnostics, preventive measures, and antimicrobial stewardship strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.